{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foverlooked.simplecast.com%2Fepisodes%2Frecurrence-GR4MZ_YL","width":444,"version":"1.0","type":"rich","title":"Recurrence","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/aade2f62-f6c9-4427-816f-ae4e861b0d27/80888ed8-cf38-4f2c-89d3-481da8f10323/season-202-20podcast-20cover.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/efc65914-95af-45f5-a1e9-a2d0bce8775f\" height=\"200\" width=\"100%\" title=\"Recurrence\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"The cancer comes back. (Remember that dandelion?) We learn that recurrence is a common feature of ovarian cancer because early detection is so difficult and there is no way to screen for it. But asking the question ‘why can’t we see it coming?’ leads me on a journey to learn more about - not the ovaries - but the fallopian tubes, and new innovations to try and get ahead of this cancer. \nThis episode features:\nDr James Bentley from Nova Scotia Health.\nAlison Ross, Director of Knowledge Mobilization at Ovarian Cancer Canada.\nJennifer Barton, Director of the Bio5 Institute at the University of Arizona.\n\nFor more background on this episode, go to https://overlookedpod.com/, where you can also get in touch with us.\n\n\n\n\n\n"}